In part you are correct however if you look at the historical reported quarterly revenue from Temcell you will discover that sales are not evenly distributed throughout the year. By simply multiplying the December quarter by four you have also multiplied the natural low that occurred in the December quarter.
Saying that I do think that Temcell sales could begin to stabilize. The Takeda product will however dramatically increase royalties for several years to come.
oh! Going Great, page-63
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |